University of Southern California-led researchers have discovered the structural details of a brain receptor called GPR6, ...
Summary of findings from the study and speculations from previous research. (Nishiwaki et al., npj Parkinson's Disease, 2024) ...
Michael J Fox has given an honest update on how he copes with Parkinson's disease. The star is best known for playing Marty ...
New therapies that are less intrusive but more lasting than current interventions promise to arrest and even reverse neurodegeneration.
The Movers and Shakers podcast host on how his Battersea rescue dog Derek the spaniel helped 'discover' his neurological ...
A new study from a database of millions of veterans nationwide reveals a possible connection between hearing loss and ...
SPR301 is a potential best-in-class gene therapy candidate that delivers a more stable, rationally engineered version of GCase, the enzyme ...
Blarcamesine’s safety profile indicates not requiring routine MRI monitoring, and the advantage of blarcamesine is that it is a small oral molecule that exerts clinical benefits on cognition and ...
Pathogenic mutations in LRRK2 account for 4-5% of familial and 1-2% of sporadic Parkinson’s disease. 1,2 BIIB122 (DNL151) is a selective, central nervous system-penetrant small molecule inhibitor of ...